Genetic predisposition of responsiveness to therapy for chronic hepatitis C. - Wikidata - wikimedia - TriplyDB

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

http://www.wikidata.org/entity/Q50575681

about

Gene expression and hepatitis C virus infection Evolution of interferon-based therapy for chronic hepatitis C.Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination Pharmacogenomics of drug efficacy in the interferon treatment of chronic hepatitis C using classification algorithms.Molecular and contextual markers of hepatitis C virus and drug abuse.Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age.Pattern-recognition techniques with haplotype analysis in pharmacogenomics.Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies.Role of viral and host factors in interferon based therapy of hepatitis C virus infection TGF-β receptor maintains CD4 T helper cell identity during chronic viral infections ADARs: viruses and innate immunity.Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.Assessing gene-gene interactions in pharmacogenomics.Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries.Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin.A support vector machine approach to assess drug efficacy of interferon-alpha and ribavirin combination therapy.Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C.Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome

P2860

Q27488345-72BF155D-EF5C-49D5-B9C0-A68950B78846 Q34342092-666F7407-2A03-4410-993D-96E168532A9A Q34599856-5E43CDAE-EC88-4965-85F9-0F2E23760B1F Q35205520-64D31A64-704B-4ACF-AE87-423A064AC2BF Q35660841-A48DA35D-6CC0-4912-8422-C31CA9C6289D Q35906659-3519B720-D61F-48B1-90CA-C36E00798C7E Q36691786-3B0EF871-8294-4318-B5C8-48F2A6448547 Q36890411-B6DF5E6E-DA11-45B1-B957-311ACF7754F8 Q37362240-02D0F8A4-2E7C-4038-9954-E2A2939BD196 Q37395668-9082A741-CE39-4EA3-BD1E-706E8E14884D Q37401773-6272F8CA-502F-4413-821D-F22908E3F465 Q37772959-B5EC025E-84A9-4000-88C6-EE4A464028D4 Q37986775-2CAF6649-B704-48C8-91CF-A4ECE042DA23 Q39359391-2FCAFFBF-0869-47CC-A4E1-C4210C1D5608 Q42382462-AB84B253-D283-44F4-AFFC-C91768CFEED2 Q42980284-017939DF-F371-43CF-BC14-3440EF5BC798 Q50569876-FF767616-9EBA-4D80-8B29-8B0929BB1077 Q58701375-C2D80675-5B01-40CD-99F7-35860DEF3B02

P2860

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

http://www.wikidata.org/entity/Q50575681

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

@en

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

@nl

type

label

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

@en

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

@nl

prefLabel

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

@en

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

@nl

P1433

Q50575681-E67C9B54-C1F5-4309-9D81-40D09552A504

P1476

Q50575681-0FF9E415-8D95-4C43-9604-FD149B9F2A5E

P2093

Q50575681-1E72B772-8ED1-4B2C-958D-578888B5659C

Q50575681-3189C3D6-4D8A-4227-9A38-BDBB8CC25B28

Q50575681-4831795D-90DE-4845-899F-39BAEB5F7FAE

Q50575681-5BFB68AD-2641-4550-9D39-245998B83152

Q50575681-5C41A3B2-35C3-48C8-9E92-FD1B306CAAFC

Q50575681-62EDB19A-31C1-4BBF-A5EF-612655C3042C

Q50575681-6A6EF930-0906-4CDD-B5E5-64DB4516E534

Q50575681-819E423C-6567-4BA4-B855-CD42D17203AC

Q50575681-89D181D7-0339-43F1-9E1C-3AB2A6D0953B

Q50575681-A35E60DF-A263-462E-A18F-A8835F30B7C3

P2860

Q50575681-0D5C6D28-4F93-4879-8A48-0FBE3C46B81C

Q50575681-1133767F-3556-4796-A7BB-4C1582BBAB6B

Q50575681-248964F7-A2DB-4A23-9612-413D5DF31F17

Q50575681-328B3698-8A09-4CDD-B0F6-8E3A261B3A7D

Q50575681-35B8E6DE-AED2-4C35-B29D-58E29B068506

Q50575681-371DA30D-4989-4976-8577-9E0F8FB418E6

Q50575681-3971DD0F-BCD2-4FCD-95A5-66B26B26E2B3

Q50575681-40B92F36-6580-4B46-A6F7-9F848CF0C9BE

Q50575681-4671EAA1-7067-41E3-8922-207FAC3998AC

Q50575681-575EFE2F-E485-46E5-ABF0-3296A5BFB54C

P304

Q50575681-BC5B2AC7-D241-48DC-83F1-24725D4CB1D3

P31

Q50575681-1C5205B5-28A3-4112-978B-C07B24B041E8

P356

Q50575681-909C477A-559D-400E-8496-24428C0728A1

P433

Q50575681-849B296B-1AD3-4E6B-93AB-78BD5D5E8D0F

P478

Q50575681-8B9A1840-96A1-4D06-ABF9-2A1008A1C428

P577

Q50575681-821E3E07-F13D-4D66-9D7A-4507D1EBFFC3

P5875

Q50575681-73341E03-7CF2-4B92-822D-34EF68C6DF1A

P698

Q50575681-E852BC2A-603B-4AE8-927B-9804FD19D3BE

P356

14622416.7.5.697

P1433

Pharmacogenomics

P1476

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

@en

P2093

Chia-Yen Dai

http://www.w3.org/2001/XMLSchema#string

Chuan-Mo Lee

http://www.w3.org/2001/XMLSchema#string

Ding-Shinn Chen

http://www.w3.org/2001/XMLSchema#string

Ellson Y Chen

http://www.w3.org/2001/XMLSchema#string

Jing-Houng Wang

http://www.w3.org/2001/XMLSchema#string

Ming-Lung Yu

http://www.w3.org/2001/XMLSchema#string

Ming-Yang Lai

http://www.w3.org/2001/XMLSchema#string

Monica Shian-Jy Bey

http://www.w3.org/2001/XMLSchema#string

Pei-Jer Chen

http://www.w3.org/2001/XMLSchema#string

Wan-Long Chuang

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone

Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta

Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases

Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

A New Statistical Method for Haplotype Reconstruction from Population Data

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Hepatitis C virus infection

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1

P304

697-709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14622416.7.5.697

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6899718

http://www.w3.org/2001/XMLSchema#string

P698

16886895

http://www.w3.org/2001/XMLSchema#string